Topics

Celyad’s off-the-shelf CAR-T data in colorectal cancer early, but serious toxicities haven’t appeared

15:54 EDT 5 Jul 2019 | MedCity News

Several patients in the trial of CYAD-101 combined with chemotherapy responded to treatment, but both a company executive and a gastrointestinal cancer expert cautioned the data were too preliminary to draw conclusions.

Original Article: Celyad’s off-the-shelf CAR-T data in colorectal cancer early, but serious toxicities haven’t appeared

NEXT ARTICLE

More From BioPortfolio on "Celyad’s off-the-shelf CAR-T data in colorectal cancer early, but serious toxicities haven’t appeared"

Quick Search

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...